$3.70
-0.06-1.6%
Last update: Oct 2, 4:00 PM
$3.70
-0.06-1.6%
Whitehawk Therapeutics Inc (WHWK) Stock Price, Quote, News & History
WHWKNASDAQ
| Name |
|---|
Revenue Change |
Gross Change |
EBITDA Change |
EBIT Change |
Earnings Change |
Benzinga Rankings give you vital metrics on any stock – anytime.
You can purchase shares of Whitehawk Therapeutics (NASDAQ:WHWK) through any online brokerage.
Other companies in Whitehawk Therapeutics’s space includes: AbbVie Inc (NYSE:ABBV), Amgen Inc (NASDAQ:AMGN), Gilead Sciences Inc (NASDAQ:GILD), Vertex Pharmaceuticals Inc (NASDAQ:VRTX) and Regeneron Pharmaceuticals Inc (NASDAQ:REGN).
Whitehawk Therapeutics has a consensus price target of $8.60.
The stock price for Whitehawk Therapeutics (NASDAQ: WHWK) is $3.7 last updated October 2, 2026 at 4:00 PM EDT.
There are no upcoming dividends for Whitehawk Therapeutics.
Whitehawk Therapeutics does not have any upcoming earnings scheduled.
There is no upcoming split for Whitehawk Therapeutics.
Whitehawk Therapeutics is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.
Whitehawk Therapeutics Inc is an oncology therapeutics company applying technologies to tumor biology to develop cancer treatments. Its portfolio includes three antibody-drug conjugate (ADC) candidates designed to address limitations of earlier...
